Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

10 results about "Carcinogen" patented technology

A carcinogen is any substance, radionuclide, or radiation that promotes carcinogenesis, the formation of cancer. This may be due to the ability to damage the genome or to the disruption of cellular metabolic processes. Several radioactive substances are considered carcinogens, but their carcinogenic activity is attributed to the radiation, for example gamma rays and alpha particles, which they emit. Common examples of non-radioactive carcinogens are inhaled asbestos, certain dioxins, and tobacco smoke. Although the public generally associates carcinogenicity with synthetic chemicals, it is equally likely to arise in both natural and synthetic substances. Carcinogens are not necessarily immediately toxic; thus, their effect can be insidious.

Smoking Filter

PendingUS20260248173A1Bacterial virusCarcinogen
The present disclosure relates to a filter for a smoking device, such as, but not limited to, a water pipe, or a cigarette, such as, but not limited to, a cannabis cigarette. The filter includes a body that is positionable over a mouthpiece of the smoking device, to filter impurities from smoke drawn therethrough, and a base that secures the body over the mouthpiece such that smoke is drawn therethrough, prior to inhalation by a user. The body can include one of more filtration layers, such as a first layer formed from a material selected to filter carcinogens and other impurities from the smoke prior to inhalation, and a second layer formed from a material selected to minimize or prevent the transmission of bacteria, viruses, or other contagions from a user's mouth to the smoking device. Each of the filtration layers can also be formed from one or more materials.
Owner:SNAP WRAP LLC

Portable bacterial toxin detection device

ActiveCN310006849SBiotechnologyCarcinogen
1. The name of the design product: portable bacterial toxin detection equipment. 2. The use of the design product: portable equipment for bacterial, toxin, and carcinogen detection. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: front view.
Owner:丁浩峰

Activity detection method of formamidopyrimidine-DNA (Deoxyribose Nucleic Acid) glycosylase

The invention discloses an activity detection method of formamide pyrimidine-DNA (deoxyribonucleic acid) glycosylase, which comprises the following steps: providing a double-chain probe which comprises two complementary single-chain probes containing 8-oxoG (8-oxoG) modification sites; uniformly mixing the Fpg enzyme, the double-stranded probe, a buffer solution and water to form a mixed system; carrying out PCR (Polymerase Chain Reaction) on the mixed system, and cutting the double-stranded probe containing the 8-oxoG modification site by using Fpg enzyme to obtain a longer and shorter fragment sample; performing electrophoresis on the fragment sample by using non-denaturing polyacrylamide gel; the non-denaturing polyacrylamide gel obtained after electrophoresis is completed is subjected to vibration dyeing, and a dyeing result is photographed so as to detect the activity of the Fpg enzyme. Compared with the prior art, the method is relatively simple and easy to operate, the reagent cost is relatively low, and the experimental result is sensitive and easy to observe; no radioactive and cancerogenic substance pollution exists, and the method is environment-friendly.
Owner:GETEIN BIOTECH

Bone cement injection device

PCT designated stageWO2026049470A1Infusion syringesSurgical needlesXylyleneCarcinogen
The present invention relates to a bone cement injection device and, more specifically, to a bone cement injection device comprising: a bone cement injection tool; and a syringe for injecting bone cement. The syringe for bone cement injection of the present invention uses polyphenylsulfone as a main component such that even when filled with bone cement used in bone-related surgery, the syringe does not undergo deformation and does not release carcinogens, thereby enabling safer use. In addition, the scale of the syringe for bone cement injection of the present invention is displayed as an engraved marking rather than with conventional xylene dye, such that the scale is not erased by organic solvents that dissolve bone cement and does not cause carcinogens, thereby providing a safe syringe for bone cement injection.
Owner:CHO CHUL MIN

A kettle with purifying function and its using method

ActiveCN116392020BBeverage vesselsNatural organic matterCarcinogen
The application discloses a kettle with purification function and a use method thereof. The kettle comprises a heating kettle and a filter kettle communicated with the heating kettle through a water inlet pipe. A main heater is arranged at the bottom of the heating kettle. A porous boiling stone is arranged at the bottom of the heating kettle. A steam outlet is arranged at the top of the heating kettle, which is used for increasing bubbles and improving the removal rate of residual chlorine. The main heater is connected with the output end of a controller. The input end of the controller is connected with a timer and a temperature sensor for collecting the water temperature in the heating kettle. The controller is used for controlling the main heater to continuously heat for a set time after boiling, and then controlling the main heater to work intermittently, so that the water temperature in the heating kettle is kept in a set temperature range. The kettle with purification function and the use method thereof are used for reacting with natural organic matters in raw water, removing chlorine and removing carcinogenic substances (trihalomethane and trihalomethane) generated in the water purification process, which is more beneficial to the health of human bodies.
Owner:WENZHOU UNIV

A method of preparing a nicotinamide mononucleotide co-crystal

The present application aims to solve the poor flowability of existing nicotinamide mononucleotide (NMN) single material flow, which leads to poor flowability, uneven mixing and poor content uniformity during preparation of NMN preparation product, and provides a safe and good flowability nicotinamide mononucleotide-proline co-crystal preparation method, the co-crystal uses Cu-Ka radiation, and the X-ray powder diffraction expressed by 2θ angle has diffraction peaks at 5.5±0.2° and 16.8±0.2°, the co-crystal has good bulk density and flowability, can realize direct tabletting or filling capsule operation of powder, the product weight difference meets the requirements of pharmacopoeia, and the operation is simple, more suitable for commercial production, at the same time, the natural amino acid-proline is used as a co-crystal former, which is safer and more reliable than the existing technology disclosed isoniazid (WHO is listed as a class 3 carcinogen).
Owner:JIANGSU XINYOU BIOLOGY CO LTD

A nicotinamide mononucleotide-proline cocrystal and its composition

ActiveCN117285582BOrganic active ingredientsSugar derivativesCarcinogenIsoniazid
This invention aims to solve the problems of poor flowability of existing nicotinamide mononucleotide (NMN) single material, leading to poor flowability, uneven mixing, and poor content uniformity in NMN formulation preparation. It provides a safe and highly flowable nicotinamide mononucleotide-proline co-crystal. This co-crystal exhibits diffraction peaks at 5.5±0.2° and 16.8±0.2° using Cu-Ka radiation and X-ray powder diffraction at 2θ angles. This co-crystal possesses good bulk density and flowability, allowing for direct tableting or capsule filling of the powder. The product weight variation meets pharmacopoeia requirements, and the process is simple, making it suitable for commercial production. Furthermore, proline, a natural amino acid and a component of collagen, is safer and more reliable as a co-crystal form than isoniazid (classified as a Group 3 carcinogen by the WHO), which is disclosed in existing technologies.
Owner:JIANGSU XINYOU BIOLOGY CO LTD

A method for low temperature smoking of bacon and a low temperature smoking chamber

PendingCN122250508AEliminate chemical preconditionsreduce the risk of fireCombination devicesMeat/fish preservationOil and greaseCarcinogen
The application relates to a method and a special smoking room for low-temperature smoked bacon, and relates to the technical field of meat product deep processing and food machinery engineering. The special part is that a special low-temperature smoking room is used for temperature section smoking: first stage smoking: the smoke temperature is adjusted through a circulating water cooling device, the smoke gas temperature contacted by the bottom layer of bacon blanks in the bacon smoking room is controlled to be 20-25 DEG C, the smoke gas temperature contacted by the top layer of bacon blanks is controlled to be 15-20 DEG C, and smoking is carried out for 2-4 months; second stage smoking: the smoke gas temperature contacted by the bottom layer of bacon blanks in the bacon smoking room is controlled to be 30-35 DEG C, and the smoke gas temperature contacted by the top layer of bacon blanks is controlled to be 25-30 DEG C. Beneficial effects: the oil and fire are separated, and the problem of carcinogens such as benzo[a]pyrene generated by high-temperature cracking of oil is completely eliminated. Meanwhile, the fire risk is greatly reduced, the disadvantages of 'upper maturation and lower growth' or local overheating in the traditional process are eliminated, the controllability of process parameters is high, and a reliable technical path is provided for the standardization and large-scale production of bacon.
Owner:ANHUA COUNTY LAYOUTANG FOOD CO LTD

Multi-stage bladder cancer model and construction method and application thereof

The invention relates to the technical field of animal models, and particularly discloses a multi-stage bladder cancer model and a construction method and application thereof. According to the application, specific components of common cigarette extracts popular in the market are identified, urine components of clinical smokers are collected and detected, the fact that benzene and NKK exist in the cigarettes and the urine of the smokers at the same time is successfully found, and the cigarette components benzene and NKK are selected for bladder cancer modeling; benzene and NNK are strong cancerogens existing in tobacco components and urine of smokers, the content of the components is high, the physiological and pathological process of bladder cancerization caused by long-term stimulation after the smokers inhale smoke, enter blood through lungs and form urine through kidneys can be directly simulated, and real life conditions are better met. The multi-stage bladder cancer model is closer to biological characteristics of bladder cancer, has specific exposure factors, and is short in preparation period, high in tumor formation rate, high in operability and good in repeatability.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY

Method for detecting cancerogen in sulfadoxine

PendingCN121577779AComponent separationDimethylaniline N-oxideCarcinogen
The invention relates to a method for detecting carcinogens in sulfadoxine. The method comprises the following steps: 1, preparing a blank solution and a test solution; 2, preparing a reference substance solution; and 3, taking the blank solution, the reference solution and the test solution, respectively carrying out gas chromatography determination in a gas chromatograph, recording a chromatogram, recording peak areas of trichloroethylene, aniline and N, N-dimethylaniline, and calculating the content of trichloroethylene, aniline and N, N-dimethylaniline in the sulfadoxine sample. By improving sulfadoxine pretreatment, limiting specific chromatographic conditions and accurately controlling detection conditions, the detection method disclosed by the invention is high in sensitivity, short in analysis time, high in specificity, relatively good in accuracy and precision and high in repeatability, and can meet sample detection requirements.
Owner:GUILIN PHARMA